Human Pan-Cancer Drive Gene Mutations Detection Kit (High-Throughput Sequencing)

Primary DI

06972665700271

Basic UDI-DI Code

B-06972665700271

Reference

Lotus NL B.V. Koningin Julianaplein 10, 1e Verd, 2595AA, The Hague, Netherlands. E-mail:[email protected]

Device Types

Single use Sterilization

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

XIAMEN SPACEGEN CO.,LTD.

The kit is intended for the detection of gene somatic mutations in peripheral blood or FFPE pathological tissue collected from patients with pan-cancer drive gene mutations.The gene mutations detected by this kit cover 56 gene hotspot somatic mutations, including single-base mutations, insertions, deletions and gene fusion mutations and other types of mutations.These mutations are related to targeted drug use. Sexuality mainly comes from domestic and foreign literature reports, and has been generally recognized by clinical treatment.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).